Favipiravir and Ribavirin Treatment of Epidemiologically Linked Cases of Lassa Fever. - Test2 - elhamkhani - TriplyDB

Favipiravir and Ribavirin Treatment of Epidemiologically Linked Cases of Lassa Fever.

Favipiravir and Ribavirin Treatment of Epidemiologically Linked Cases of Lassa Fever.

http://www.wikidata.org/entity/Q41920062

about

Control measures following a case of imported Lassa fever from Togo, North Rhine Westphalia, Germany, 2016.New Lineage of Lassa Virus, Togo, 2016.What Pediatricians Should Know About Lassa Virus.A Highly Conserved Leucine In Mammarenavirus Matrix Z Protein Is Required For Z Interaction With The Virus L Polymerase And Z Stability In Cells Harboring An Active Viral Ribonucleoprotein.Baseline mapping of Lassa fever virology, epidemiology and vaccine research and development.Effective Treatment of Experimental Lymphocytic Choriomeningitis Virus Infection: Consideration of Favipiravir for use with Infected Organ Transplant Recipients.Absence of Nosocomial Transmission of Imported Lassa Fever during Use of Standard Barrier Nursing Methods.Structure of the Lassa virus glycan shield provides a model for immunological resistance A Case of Lassa Fever Diagnosed at a Community Hospital-Minnesota 2014 Recent advances in understanding Crimean-Congo hemorrhagic fever virus Use of Favipiravir to Treat Lassa Virus Infection in Macaques An overview of Lassa fever

P2860

Q41919417-168073BA-8824-411C-90C8-F2898221847E Q49819995-64B145B5-0302-4A37-9B5D-3ABA19B01A60 Q50420736-63612A71-477A-4256-A909-6D09C5B13FB1 Q52625016-58ACB5AE-3F19-42DD-AF66-CC146B78AEEA Q52723914-B03FCCF2-F004-494E-9FF8-39D5AEB925B8 Q54211351-BF78354F-9C4C-4BC2-9BBE-F8B22E2F691D Q55246727-927B9E54-2AC8-452A-BAF4-08D5A9BA4737 Q56941600-EF793584-BCEF-4061-A383-4E44BE5F317B Q57002447-54FDD576-4C31-4C9F-9388-1AE719F07354 Q58706047-ABCC397B-9420-4901-B8FC-61EBD7E879D4 Q58777764-54D6C571-9FEF-464A-85AE-1E778529EB89 Q71419342-9f421ee2-475c-70e7-5515-c9241d5732cc

P2860

Favipiravir and Ribavirin Treatment of Epidemiologically Linked Cases of Lassa Fever.

http://www.wikidata.org/entity/Q41920062

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年論文

@yue

2017年論文

@zh-hant

2017年論文

@zh-hk

2017年論文

@zh-mo

2017年論文

@zh-tw

2017年论文

@wuu

2017年论文

@zh

2017年论文

@zh-cn

name

Favipiravir and Ribavirin Treatment of Epidemiologically Linked Cases of Lassa Fever.

@en

type

label

Favipiravir and Ribavirin Treatment of Epidemiologically Linked Cases of Lassa Fever.

@en

prefLabel

Favipiravir and Ribavirin Treatment of Epidemiologically Linked Cases of Lassa Fever.

@en

P1433

Q41920062-650D5FA8-73A3-47D2-98A8-A4CE23BE1BF0

P1476

Q41920062-9432BC53-1487-4C2D-BD91-3EC0D940D851

P2093

Q41920062-23E8754A-EEBB-421E-9CBD-948389A6368C

Q41920062-3CA9B4F4-73F6-41D5-A17E-7828FA407A12

Q41920062-463C0B72-59C9-4C39-9729-53F774D52519

Q41920062-50C3AD11-F085-4125-B631-96CC8F96324C

Q41920062-52E5599B-6F3C-4187-B197-0932918A6606

Q41920062-54201735-1326-4004-BB9C-0660A8CC95E0

Q41920062-55BB4FAA-CC3F-4E3C-8D46-2D9047B73C0D

Q41920062-5EB5856A-5695-4994-9917-E77DFD541663

Q41920062-640426C3-6622-4B60-A1D9-C38C22696871

Q41920062-70F86B8A-FC52-482A-9792-E764F344AB10

P2860

Q41920062-08B59359-C6DC-4050-BD2C-F5B55983F492

Q41920062-0C2A153A-9663-4DE0-B2ED-09BD5481B609

Q41920062-1861BFD7-7E67-4611-88EF-5CFF6EFF1F77

Q41920062-291AAF56-FC28-4521-831E-89162CE06095

Q41920062-372C6A75-AA0F-4A2C-BFB7-655A2F82F1B2

Q41920062-3CF425E2-2622-458F-AFC5-0557D9D53576

Q41920062-9BD88045-3913-46EE-B5FB-A83DC40DA246

Q41920062-A07EDDC5-1CEF-475B-8954-4DFC04FB7FB6

Q41920062-A84FC3CB-2FFF-4459-AA37-822FD49DF8FD

Q41920062-B01E201A-9D3B-43C2-A829-3A28C3B1011E

P304

Q41920062-C65B5DDB-AEE4-460F-89ED-C0667F9920FF

P31

Q41920062-352E1E7B-796F-4F3A-B8A3-64D6A8B77235

P356

Q41920062-A9AB4CA4-8C7C-4478-A11E-4CDD07EB93D8

P407

Q41920062-443E2405-869D-4162-AA68-033A893AFB77

P433

Q41920062-8C037DA8-154D-4532-911C-87150DA6D1DD

P478

Q41920062-D7488F5E-92E3-423B-A4A1-745DC1B08E81

P50

Q41920062-44E6DFDC-2AB6-4B9A-B796-6D92A06E36AA

Q41920062-464A316D-09FC-497B-85E7-EA16BB708667

Q41920062-84FC6B15-3E21-409A-A6D8-EB17D418D386

P577

Q41920062-EE1D7A39-4C24-48BE-9224-E3A0721D4CAF

P698

Q41920062-89FD7491-8897-467B-B867-76E9E2751163

P921

Q41920062-5BA516E7-1927-4BD6-B0E0-701FCED6575C

Q41920062-B6373864-8E2E-4A7A-8E1B-F28981E56BD2

Q41920062-C72A8C34-3DAD-4D48-B16E-D752D04ACBBF

P932

Q41920062-B6BFC288-A933-445B-835B-19BB05D7735F

P356

P1433

Clinical Infectious Diseases

P1476

Favipiravir and Ribavirin Treatment of Epidemiologically Linked Cases of Lassa Fever.

@en

P2093

Andres Morales

http://www.w3.org/2001/XMLSchema#string

Aneesh K Mehta

http://www.w3.org/2001/XMLSchema#string

Anita McElroy

http://www.w3.org/2001/XMLSchema#string

Bruce S Ribner

http://www.w3.org/2001/XMLSchema#string

Christoph Stephan

http://www.w3.org/2001/XMLSchema#string

Colleen S Kraft

http://www.w3.org/2001/XMLSchema#string

Emory Serious Communicable Diseases Unit

http://www.w3.org/2001/XMLSchema#string

G Marshall Lyon

http://www.w3.org/2001/XMLSchema#string

Gerrit Kann

http://www.w3.org/2001/XMLSchema#string

Gundolf Schuettfort

http://www.w3.org/2001/XMLSchema#string

P2860

Persistence of Ebola Virus in Ocular Fluid during Convalescence

Experimental Treatment with Favipiravir for Ebola Virus Disease (the JIKI Trial): A Historically Controlled, Single-Arm Proof-of-Concept Trial in Guinea

Monitoring of clinical and laboratory data in two cases of imported Lassa fever.

Lassa fever. Effective therapy with ribavirin

Using modelling to disentangle the relative contributions of zoonotic and anthroponotic transmission: the case of lassa fever

The broad-spectrum antiviral favipiravir protects guinea pigs from lethal Lassa virus infection post-disease onset.

Efficacy of Favipiravir Alone and in Combination With Ribavirin in a Lethal, Immunocompetent Mouse Model of Lassa Fever.

Improved detection of Lassa virus by reverse transcription-PCR targeting the 5' region of S RNA.

RT-PCR assay for detection of Lassa virus and related Old World arenaviruses targeting the L gene.

Absence of CTL responses to early viral antigens facilitates viral persistence.

P304

855-859

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1093/CID/CIX406

http://www.w3.org/2001/XMLSchema#string

P407

P433

5

http://www.w3.org/2001/XMLSchema#string

P478

65

http://www.w3.org/2001/XMLSchema#string

P50

Stuart T Nichol

Pierre E Rollin

P577

2017-09-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29017278

http://www.w3.org/2001/XMLSchema#string

P921

P932

5682919

http://www.w3.org/2001/XMLSchema#string